David Schilansky
Bioinformatics & Systems Biology
Dbv Technologies
France
Biography
David Schilansky was appointed Chief Operating Officer and deputy Chief Executive Officer in January 2015, and is a member of the Board of Directors and Executive Committee. In this role, he supports the CEO in all strategic initiatives and corporate governance matters, supervising Strategy and Finance, Human Resources, Legal, Communications, as well as Business Development. Mr. Schilansky joined DBV as Chief Financial Officer in December 2011. Previously, Schilansky held various senior positions at Ipsen Pharma, including Interim Chief Financial Officer. Earlier in his career, he spent three years at Thomson Inc. (now Technicolor S.A.) as co-head of investor relations and three years at Warburg Dillon Read (now UBS) in the field of mergers and acquisitions. Mr. Schilansky received a master’s degree from Université de Paris Dauphine and a post-graduate degree from Imperial College in London.
Research Interest
Bioinformatics & Systems Biology
